论文部分内容阅读
DNA methyl-transferase 3A(DNMT3A) mutation has recently been identified as an independent risk factor for patients with acute myeloid leukemia(AML). However, reports are scanty on its rate and subsequent impact on patients with acute lymphoblastic leukemi